Home > Products > CD19 & CD22
> Human Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-IgG)
Human Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H214)
Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD19 and anti-CD22 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Human Anti-CD19 x Anti-CD22 Bispecific Antibody (IgG-IgG) (BSIG-H214). Click the button below to contact us or submit your feedback about this product.